TP53 p.Pro72Thr
c.214C>A · rs587782769 · VCV232750
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0613 | likely benign |
|---|---|---|
| REVEL | 0.273 | benign-leaning |
| SaProt | LLR -8.23 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -0.19 | GERP -2.2 |
| Regional constraint | o/e 0.89 | unconstrained · MANE · 6,982 bp · p 0.0085 · regional, not allelic |
| Overall | ||
| CADD | 3.417 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,464 |
| European (non-Finnish)grpmax | 0.000254% | 393,324 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- TP53
- Protein
- p.Pro72Thr
- Coding
- c.214C>A
- MANE Select
- NM_000546
- dbSNP
- rs587782769
- Type
- single nucleotide variant
- Location
- chr17:7676155 (GRCh38)
- Gene constraint
- LOEUF 0.449 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 75.83 · 321 PDB
- Residue 72
- a UniProt-annotated variant site (in sporadic cancers; somatic mutation; requires 2 nucleotide substitutions); a UniProt-annotated variant site (in sporadic cancers; somatic mutation); a UniProt-annotated variant site (in a sporadic cancer; somatic mutation); a UniProt-annotated variant site (in); the 'interaction with ccar2' region; the 'interaction with hrmt1l2' region; the 'disordered' region; the 'interaction with wwox' region
Similar variants
- TP53 p.Pro72Ala Likely benign ★★★ same residue
- TP53 p.Pro72Arg Benign ★★★ same residue
- TP53 p.Pro72His Benign ★★★ ⚠ same residue
- TP53 p.Pro72Leu Conflicting classifications of pathogenicity ★ ⚠ same residue
- TP53 p.Pro72Cys Uncertain significance ★★★ same residue
- TP53 p.Pro72Ser Uncertain significance ★★ same residue
- TP53 p.Pro72fs Pathogenic ★ same residue
- TP53 p.Pro72_Val73delinsArgMet Conflicting classifications of pathogenicity ★ same residue
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/tp53-p-pro72thr (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown